Optimal Freeze Cycle Length for Renal Cryotherapy
Overview
Authors
Affiliations
Purpose: To our knowledge the optimal freeze cycle length in renal cryotherapy is unknown. Ten-minute time based freeze cycles were compared to temperature based freeze cycles to -20C.
Materials And Methods: Laparoscopic renal cryotherapy was performed on 16 swine. Time based trials consisted of a double 10-minute freeze separated by a 5-minute thaw. Temperature based trials were double cycles of 1, 5 or 10-minute freeze initiated after 1 of 4 sensors indicated -20C. A 5-minute active thaw was used between freeze cycles. Control trials consisted of cryoneedle placement for 25 minutes without freeze or thaw. Viability staining and histological analysis were done.
Results: There was no difference in cellular necrosis between any of the temperature based freeze cycles (p = 0.1). Time based freeze cycles showed more nuclear pyknosis, indicative of necrosis, than the 3 experimental freeze cycles for the renal cortex (p = 0.05) but not for the renal medulla (p = 0.61). Mean time to -20C for freeze cycle 1 was 19 minutes 10 seconds (range 9 to 46 minutes). In 4 of 21 trials (19%) -20C was never attained despite freezing for 25 to 63 minutes.
Conclusions: There was no difference in immediate cellular necrosis among double 1, 5 or 10-minute freeze cycles. Cellular necrosis was evident on histological analysis for trials in which -20C was attained and in freeze cycles based on time alone. With a standard 10-minute cryoablation period most treated parenchyma 1 cm from the probe never attained -20C. Cell death appeared to occur at temperatures warmer than -20C during renal cryotherapy.
Image-guided percutaneous ablative treatments for renal cell carcinoma.
Auer T, Uluk Y, Grasso R, Kloeckner R, Gebauer B, Kroencke T Eur Radiol. 2025; .
PMID: 40050457 DOI: 10.1007/s00330-025-11480-w.
Multipoint Thermal Sensors Associated with Improved Oncologic Outcomes Following Cryoablation.
Martin J, Patel R, Okhunov Z, Vyas A, Vajgrt D, Clayman R J Endourol. 2017; 31(4):355-360.
PMID: 28114787 PMC: 5397231. DOI: 10.1089/end.2016.0864.